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ABSTRACT
Sickle cell disease is a severe hereditary disease caused by an abnormality of the red
blood cells. The current therapeutic decision-making process applied to sickle cell
disease includes monitoring a patient’s symptoms and complications and then
adjusting the treatment accordingly. This process is time-consuming, which might
result in serious consequences for patients’ lives and could lead to irreversible
disease complications. Artificial intelligence, specifically machine learning, is a
powerful technique that has been used to support medical decisions. This paper aims
to review the recently developed machine learning models designed to interpret
medical data regarding sickle cell disease. To propose an intelligence model, the
suggested framework has to be performed in the following sequence. First, the data
is preprocessed by imputing missing values and balancing them. Then, suitable
feature selection methods are applied, and different classifiers are trained and tested.
Finally, the performing model with the highest predefined performance metric over
all experiments conducted is nominated. Thus, the aim of developing such a model is
to predict the severity of a patient’s case, to determine the clinical complications of
the disease, and to suggest the correct dosage of the treatment(s).
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1. Introduction
Sickle cell disease (SCD) is a severe
hereditary disease that critically
influences the patient’s quality of life
because of red blood cell abnormality
(Khalaf et al., 2017). SCD was first
discovered in 1910 (Wailoo, 2017), and
today about 5% of the human
population are healthy carriers of a gene
for either sickle cell anemia or
thalassemia. Every year, it is estimated
that more than 300,000 newborns with
severe forms
of these diseases are born globally, with
the majority of new cases being born in
low and middle income countries
(WHO, n.d.). According to Rogers
(Rogers, 2017), SCD is predominant
among citizens of the following
regions/countries:
Africa,
the
Caribbean, India, the Middle East, and
the Mediterranean. Specifically, studies
have shown that SCD is a quite
common genetic disorder in Saudi
Arabia. In some areas, the carrier status
of SCD varies from 1.4% to 2%, and
reaches up to 27% (El-Hazmi et al.,
2011). The Saudi premarital screening
program has estimated the incidence of
SCD in the adult population at 0.26%
for SCD and 4.2% for the sickle cell
trait, with the highest incidence
observed in the Eastern province
(approximately 1.2% for SCD, and 17%
for the sickle cell trait) (El-Hazmi et al.,
2011). The current therapeutic decisionmaking process includes monitoring
symptoms and complications of the
disease, then adjusting the treatment
accordingly (Creary and Strouse, 2014).
This process can result in serious
consequences affecting the patient’s
quality of life and could lead to late

medical interventions and irreversible
disease complications. The current
evaluation process is also difficult and
time consuming for medical staff.
Pre-symptomatic prediction of the
severity of SCD for patients is a
complex problem (Quinn, 2016). Using
artificial intelligence (AI) techniques,
more specifically machine learning
(ML) models, to predict the severity of
SCD for
diagnosed
patients
may
assist
physicians and clinicians in the
therapeutic decision-making process by
using data collected from patients
diagnosed with SCD.
This paper reviews the systems
currently applied ML techniques to
interpret medical data regarding SCD.
Most of these systems predict the
severity of SCD for diagnosed patients,
while
the
remaining
(currently
available) systems are also used to
suggest the proper dosage of the
treatment drug (hydroxyurea) to prevent
any disease complications. All proposed
systems apply AI, specifically ML
techniques, in the medical field and can
be used to help physicians with both
diagnosis and drug prescription
processes.
The ability to predict the severity of
SCD in diagnosed patients could
advance medical research regarding the
treatment process, alter the therapeutic
decision-making
conditions
for
physicians, and drastically improve the
quality of life for patients with SCD
(Creary and Strouse, 2014).
The remainder of the paper is
organized in the following manner.
Section 2 presents a clinical background
on SCD. Section 3 presents a technical
background about ML algorithms used
in the medical field. In addition, Section
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4 provides a summary of recent
literature about predicting the severity
of SCD and the estimation of drug
dosage. Finally, Section 5 states the
conclusion of this paper and suggests
future challenges.
2. Clinical Background
2.1. SCD Description
Blood is a red viscous fluid consisting
of red and white blood cells, plasma,
and platelets. It flows into blood
vessels and arteries, and is produced in
the bone marrow. The heart muscle
pumps the blood to all parts of the
body, transferring nutrients and oxygen
to all the cells, allowing the body to
carry out its necessary functions (MOH,
n.d.).
Red blood cells are a group of cells that
number up to four or five million cells
per cubic millimeter of blood fluid. The
function of the red blood cells is to
transport gases. These cells are
distinguished by the pigment of
hemoglobin which they contain, making
the blood red. They bind the elements
of iron, protein, and hemoglobin with
oxygen and then transport these
nutrients to the parts of the body. Red
blood cells are prone to certain diseases,
including
malaria,
hemophilia,
thalassemia, anemia, and sickle cell
anemia (MOH, n.d.).
Hemoglobin is an iron-rich, red
compound that provides blood its red
color. Hemoglobin permits red blood
cells to transmit oxygen from the
human lungs towards all parts of the
human body (Rogers, 2017). SCD is a
hereditary disease that modifies red
blood cells. Red blood cells are usually
circular, but in SCD patients, the cells
take on the abnormal form of a crescent.

The disease makes the sickle-shaped
cells sticky and causes them to build-up
in small blood vessels producing slow
blood flow, which prevents oxygen
from traveling to the rest of the body.
Sickle red blood cells live between 10
and 20 days, whereas normal cells
survive up to 120 days (MOH, n.d.).
Sickle cell anemia is a long-term
disease that has a serious impact on the
expectancy and quality of life for
patients. There are many complications
resulting from sickle cell anemia, and
most of these complications require
emergency medical intervention. The
most prominent of these serious
complications are: (i) Acute chest
syndrome, (ii) avascular necrosis, (iii)
organ damage such as liver, kidney, and
spleen, (iv) priapism, (v) pulmonary
embolism (a condition of increased
blood pressure within the arteries of the
lungs), (vi) stroke, (vii) and tissue
damage (CDC, 2020).
The sickle cell gene travels from
one generation to another in a
hereditary pattern known as the
autosomal recessive genotype. Hence,
the parents must pass on the defective
gene in order for the child to become
infected. The person needs two copies
of the gene to acquire the disease.
1. Both mother and father are trait
carriers.
2. Both mother and father are infected.
3. One is infected and the other is a
carrier (MOH, n.d.).
2.2. SCD Types
Despite the multiple types of SCD
disease, they are all similar in
symptoms, yet they differ in severity.
There are four types of sickle cell
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anemia, depending on the mutation that
affects the person’s genes.
1. Hemoglobin SC disease
2. Hemoglobin SS disease
3. Hemoglobin disease SB 0 beta-zero
thalassemia
4. Hemoglobin disease SB +
In addition, there are other types of
disease, although very rare, such as
hemoglobin SD, hemoglobin SE, and
hemoglobin SO (Rogers, 2017). The
three main types of SCD can be
explained as follows. The first and most
prevalent is the case called Hb SS,
which occurs when a patient inherits
sickle cell genes from both parents. The
second one is called Hb SC, and occurs
when the patient inherits the sickle cell
gene (S) and another gene that is
generated from an irregular form of
hemoglobin (C). Finally, if the patient
inherits both beta thalassemia and the
sickle cell gene, then the disorder is
called s-beta thalassemia (Khalaf et al.,
2017).

4. Vaccination

2.3. Suggested Treatments of SCD

3. Machine Learning Techniques in
Medical Fields

Most medical centers use manual
methods, such as observing blood
sample test results and/or using the
patient’s history, to estimate both the
severity of the disease and to give the
correct dosage of treatment to the
patient. This method depends on the
experience of doctors (MOH, n.d.). So
far, there is no definitive cure for the
disease, but there are treatments that
can alleviate the pain and help prevent
the problems associated with SCD
(MOH, n.d.). Such treatments include:
1. Blood transfusions
2. Medication to relieve pain such as
morphine
3. Folic acid supplements to strengthen
healthy blood cells

and antibiotics to
prevent infection
5. Marrow transplantation
6. Home care and healthy living (very
important factors for these patients)
7. Hydroxyurea
Research has proven the beneficial
effects of the drug, hydroxyurea. It
could reduce the rate of the disease by
50% and indicates continuous long-term
benefits, including the hindrance of
organ damage. This medication is given
orally, once every day, and comes in
liquid or capsule form. The drug works
by modifying the disease phenotype,
which helps to increase hemoglobin
production and keeps red blood cells
round and breakable. This allows the
cells easy access to body parts. This
treatment is one of the most successful
treatments (Luzzatto and Makani,
2019), and it has been clinically proven
to
reduce
the
above-mentioned
complications (Creary and Strouse,
2014).

In recent years, the use of AI in
medicine
has
been
discussed
extensively in the literature. AI can
apply powerful techniques to ‘learn’
from the huge volumes of available
health care knowledge. It has also
sparked an energetic debate on whether
AI systems could potentially substitute
human physicians in the future (Jiang et
al., 2017). Currently, as a result of the
vast quantity of data and the continuous
improvement of developed analytical
methods, many attempts have been
made to build systems to assist
physicians in various medical tasks,
such as early detection, diagnosis of
diseases, and recommending and
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•

•

•

•

prescribing treatment. (Jiang et al.,
2017). Before ML systems can be used
in the medical field, they must be
trained using data from clinical
activities. Depending on the type of the
patient’s problem, data could be derived
from diagnoses, patient treatment plans,
laboratory tests, or other general patient
information, such as age or sex. The
machine learning algorithms can be
divided into three main categories:
Supervised learning: All data points are
labeled. This process works on
predictive modeling by detecting
relationships and patterns between input
and output.
Unsupervised learning: This process
works with unlabeled data, and is well
known for feature extraction and
clustering.
Semi-supervised learning: In this
process, some data points are labeled,
making it a hybrid of the two types
above-mentioned.
Reinforcement learning: This is called
an agent, and it functions in an iterative
way. The agent learns from its
experiences until it discovers the full
range of all possible states in the
environment.
In medicine, ML applications most
frequently use supervised learning
classifiers because they provide more
significant results than unsupervised
ones. In the preprocessing step,
unsupervised learning can be used to
identify patterns in data or reduce
dimensionality, hence making the
consequence step more effective.
Various ML algorithms have been used
in medical applications such as artificial
neural network (ANN), support vector
machine (SVM), random forest (RF),
and logistic regression (LR). Figure 1
shows the common supervised learning

techniques used in medical fields, and it
visibly demonstrates that SVM and
ANN are the most common types.
However, this fact remains true only
when limited to the three main data
types
(image,
genetic,
and
electrophysiological) (Jiang et al.,
2017).

Figure 1. Most commonly used
supervised learning techniques in
medical fields (Jiang et al., 2017)
Next, the authors review the most
widely-used supervised ML algorithms
within medical applications. SVM is
included because it is the most
successful algorithm for accuracy in
medical diagnosis (Goyal et al., 2018).
In addition, RF is considered because it
is the best performing algorithm in
predicting SCD severity (Mohammed et
al., 2019). Lastly, ANN algorithms are
included because they have succeeded
in various
medical applications
(Yasnitsky et al., 2015).
SVM Algorithm
SVM is one of the most notable
supervised ML algorithms that can be
employed to solve both regression and

50
https://digitalcommons.aaru.edu.jo/fcij/vol5/iss1/4
DOI: http://doi.org/10.54623/fue.fcij.5.1.4

Alharbi et al.: Recent Advances and ML Techniques on Sickle Cell Disease

classification problems, but it is usually
ANN Algorithm
employed for binary classification.
ANNs are a type of biologically
Finding a suitable hyperplane in an Ninspired algorithms aiming to replicate
dimensional space (N — the number of
the functionality of the human brain.
features) that specifically classifies the
They
are
considered
powerful
data points is the objective of the SVM
computational models that are capable
algorithm (Gandhi, 2018).
of solving many complex tasks that
The main advantages of using SVM
involve generalization (Yasnitsky et al.,
are its memory efficiency and its
2015). These intelligent networks
efficiency in high-dimensional spaces.
consist of a collection of connected
On the other hand, this algorithm does
artificial neurons, similar to biological
not function well on large datasets or
neurons in the brain. These neurons are
datasets with noise (Dhiraj, 2018). For
formed in layers, and different layers
SVM implementation, the most proven
perform various transformations on
convex optimization techniques are
their inputs.
readily available. The SVM algorithm
• Input layer: The first layer in an ANN
has been widely applied in medical
that receives raw input and represents
fields. It has been applied to achieve
the beginning of the network workflow.
early detection of Alzheimer’s disease
• Hidden layer: This is used in multiand the diagnosis of cancer (Jiang et al.,
layered networks. It is the layer located
2017).
between the input layer and the output
layer, where neurons receive a set of
RF Algorithm
weighted inputs and generate an output
Another commonly used supervised
via an activation function.
learning algorithm for both regression • Output layer: The last layer in an ANN
and classification is RF. The reason for
that generates the output of the network.
naming the algorithm “random forest”
Inputs have to be multiplied by
is because the algorithm creates a
weights, which modifies the strength of
“forest” from a number of decision trees
the inputs, then the neurons will
(DTs), which are the basis for this
calculate the inputs to predict the final
algorithm (Chaudhary and Vasuja,
output. The weights in an ANN are
2019). DT is the portion that falls under
modified in the training phase using
supervised learning for classification
learning algorithms.
algorithms. A tree-like structure is
Below are a few of the most popular
generated in this algorithm. The “tree”
types of ANNs:
is traversed according to the conditions
• The feedforward neural network is
needed to find an outcome. Most
the simplest implementation of an
researchers have used this technique
ANN. It is relatively easy to maintain
because it is simple and lets them
due to its simplicity. It can also deal
uncover small or large data structures
with noisy data, which is why ANNs
and predict the value (Chaudhary and
are used in technologies like computer
Vasuja, 2019).
vision and face recognition (Mehta,
2019).
• The multi-layer perceptron (MLP)
has three or more layers, and is a fully
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connected network that is used for
nonlinear problems. This type of ANN
is heavily used in natural language
processing and speech recognition
(Mehta, 2019).
• The convolutional neural network
applies multiple MLPs. It contains one
or more convolutional layers that could
be either pooled or completely
interconnected (Jiang et al., 2017). It
performs a convolutional operation on
the input before passing the result to the
next layer, and as a result, the network
can be far deeper, yet with much fewer
parameters (Mehta, 2019). Due to this
ability, convolutional neural networks
demonstrate exceptionally promising
results in image classification, image
and video recognition, and semantic
parsing (Mehta, 2019).
4. Literature Review
SCD is phenotypically variable (Quinn,
2016). The ability to predict disease
severity before patients develop any
serious complications can have
tremendous benefits for improving the
general quality of life for patients and
aid in the therapeutic decision-making
process. This section reviews several
related papers in order to compile
comprehensive knowledge of the
research. The selected literature was
chosen based on the following criteria:
1. It focuses on SCD severity or
suggests the appropriate dosage of
hydroxyurea.
2. It was published from 2015
(inclusive) until present.
3. It employs ML techniques.
Most of the reviewed literature
revolves around the prediction of the
severity of the disease from various
aspects, including organ damage, risk of
anemia, and pain score. The remainder

focuses on estimating the appropriate
dosage of hydroxyurea for SCD patients
with different machine learning
approaches.
In both (Abd Al-Maaref et al., 2017)
and (Khalaf et al., 2015a), the same
intelligent monitoring system is
proposed to monitor patient health
relying on mobile apps installed on their
smartphones. Whenever a patient enters
his or her medical information, the
developed expert system uses a ML
classifier to determine whether the
patient’s situation is critical. The data
used to train the classifier includes
patients carrying SCD traits and
patients who are not carriers. The
difference between them is the
classifiers used. In (Abd Al-Maaref et
al., 2017), an additional sample was
added to the dataset. This study (Abd
Al-Maaref et al., 2017) tested six ML
classifiers. These were JRip-Rules,
Attribute Selected Classifier, Voted
Perceptron, Bayes Net, Adaboost M1,
and Logit boost (LB). LB achieved the
best accuracy score (99.6%). In (Khalaf
et al., 2015a), multiple experiments
were carried out to identify normal
patients from SCD patients using the
following four ML algorithms: core
vector regression, MLP, hyperpipes,
and zero-rule based algorithms. The
greatest accuracy (99.5984%) was
achieved using the MLP classifier.
The authors (Ademola et al., 2018)
used ensembles of ML models to
predict the severity of SCD. The criteria
used was multiple physicians’ opinions
in each case. The data was classified by
experts into three classes: high risk,
moderate risk, and low risk. The
features also included laboratory tests.
Seven ML models were tested including
isolated classifiers, which are C4.5 DTs,
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Naïve Bayes, SVM, and ensembles of
the isolated classifiers. The best
performance was obtained by the
ensemble method that combined the
Naïve Bayes and C4.5 DTs classifiers.
In another study (Yang et al., 2018),
the authors suggested a system that
drew objective physiological measures
from subjective self-reported pain
scores by utilizing ML algorithms. The
self-reported pain score for a patient,
which ranges from 0 (no pain) to 10
(severe and unbearable pain), was
included with each data point. The
utilization of missing data was done
using
multiple
imputation.
The
researchers recommended a pain
prediction
system
for
different
situations: (i) inter-individual pain
prediction with 11 pain scores, (ii)
intra-individual pain prediction with 11
pain scores, and (iii) inter-individual
pain prediction with condensed pain
levels numbering less than 11 (6, 4 and
2 pain levels). From all these
experiments and by using the
performance measures, accuracy and F1
score, it was determined that the
multinomial LR classifier provided the
best performance measures compared to
the remaining three classifiers used in
this research (SVM, k-nearest neighbor
and RF).
An early prediction of organ failure
for patients with SCD was proposed by
(Mohammed et al., 2019). Continuous
physiologic data was collected on 63
adults based on 163 encounters. Several
classification models were tested,
including MLP, SVM, RF, and LR.
Feature selection was used for
extracting the features from each of the
physiological data streams. The results
showed that RF produced the highest
accuracy (99.57%) in predicting organ

failure prior to six hours before it
began.
As has been discussed, several ML
algorithms have been developed to
assist healthcare professionals and
physicians in estimating the severity of
SCD using AI. This estimation is
needed based on the severity of many
serious complications that SCD causes.
The authors reviewed research papers
revolving around the prediction of the
severity of the disease using different
criteria. The most frequently tested
algorithms were SVM and MLP, which
indicates their popularity in the field.
However, MLP and LB were the bestperforming algorithm among all the
reviewed papers. Table 1 summarizes
all the research papers that were
discussed in this section.
Despite the wealth of data on SCD,
predicting the severity of the disease
continues to be a complex issue, mainly
because the disease is highly
phenotypically diverse (Quinn, 2016).
This attribute has made the problem of
predicting the severity of SCD a good
candidate for the use of AI, as is
revealed in the above examples. Also,
the authors are motivated to study this
problem since few other attempts have
been made to utilize AI to aid the
therapeutic decision-making process.
Hydroxyurea is the effective drug
used to treat SCD, as mentioned in
Section 2.3. A number of studies
(Khalaf et al., 2015b), (Khalaf et al.,
2016), (Khalaf et al., 2017), have been
proposed to help medical professionals
and physicians predict the right dosage
of hydroxyurea based on blood test
results for SCD patients.
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Table 1. Prediction of Severity in SCD Review

Author

ML Algorithms

Dataset

No of No of Performance
Best Performing ML Algorithm
Patients Features Measure

(Khalaf et al., 2015a)  Core vector Two local 498
regression hospitals in the
city of
 Hyper pipes
Liverpool
 MLP
 Zero-rule based
(Abd Al-Maaref et  Adaboost Ml
Centre
250
al., 2017)
Caribéen
de
 Bayes net
ladrépanocytose
 LB
 Voted
perceptron
 JRip rules
 Attribute
selected classifier
(Ademola et al.,
 C4.5 DT Wesley Guilds NA
2018)
Obafemi
 NB
Awolowo
 SVM
University
Teaching
Hospital
Complex
(Yang et al., 2018)  K-nearest
Duke
40
University
neighbor
 Multinomial LR Hospital
 RF
 SVM

(Mohammed et al.,
2019)

 LR
 MLP
 RF
 SVM

Methodist Le
Bonheur
Hospital

63

12

Accuracy

MLP
99.5984%

12

Accuracy

LB
99.5984%

10

Accuracy & Ensemble model (DT + NB)
Precision with 86.957% Accuracy &
87.2% Precision

6

Accuracy /
Multinomial LR
F1 score 0.546 / 0.540 for 11-point scale
rating
0.681 / 0.673 for 4-point scale
rating

5

0.821 / 0.819 for 2-point scale
rating
Accuracy
RF
99.57%
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A web-based system that aids
healthcare physicians to provide SCD
patients with a suitable amount of
hydroxyurea was proposed using
different types of ML algorithms
(Khalaf et al., 2015b). In the initial
stage of its proposed methodology, the
system used a neural network consisting
of a weighted model, where ANNs are
accumulated into levels and the outputs
from one network are catered into the
subsequent in conjunction with desired
outputs. In addition, it employed
exploratory analysis using stochastic
neighbor embedding plots. In the
proposed
system,
several
ML
algorithms are used; however, the MLP
algorithm outperformed the others by
providing the lowest error rates.
An experimental study by (Khalaf et
al., 2016) shows the use of different
neural network models to predict the
appropriate dosage of medication for
SCD. The target dosage was divided
into six bins. These models are voted
perception (VP), back-propagation
trained feed-forward neural network
(BPXN), functional link neural network
(FLNN), and radial-basis neural
network (RBN) classifiers. The results
for the models in order from best to
worst using the area under the curve
measure: BPXN: 0.989, FLNN: 0.972,
RBN: 0.875, and the VP: 0.766
classifier.
To
demonstrate
the
importance of the previous models,
researchers subsequently used a linear

neural network as a baseline classifier,
which produced an area of 0.849 and a
random guessing model with an area of
0.524.
In addition, a group of researchers
proposed a methodology that employed
the holdout method to split the data
(Khalaf et al., 2017). Then, the feature
extraction method was conducted.
Subsequently, the following models
were used: SVM, RF, random oracle
model, MLP trained using the
Levenberg-Marquart learning algorithm
(LEVNN), linear combiner network,
Elman neural network, Jordan neural
network, and the Elman-Jordan hybrid
neural network. The target dosage of
treatment was divided into three bins,
and the highest accuracy/ F1 score was
achieved using LEVNN.
Thus, this paper concludes a
principle framework consisting of the
following main steps:
1. Collecting,
analyzing
and
preprocessing SCD patient data
presented by a hospital or health care
provider (including blood tests, disease
severity levels, and suggested courses
of treatment) to deal with missing
values using various missing data
imputation algorithms (Jakobsen et al.,
2017; Yang et al., 2018).
2. Selecting the best features from the
dataset by using a different filter,
wrapper, or embedded method to
improve system performance (Jain and
Singh, 2018).
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3. Applying different ML algorithms to

the dataset to determine disease severity
in newly diagnosed patients, clinical
complications associated with the
disease, and suggesting suitable patient
treatment plan(s) based on disease
severity.
5. Conclusion
Sickle cell anemia is a common yet
severe hereditary disease that has a
debilitating effect on patient life
expectancy and quality due to
complications caused by abnormal red
blood cells. Since SCD was discovered,
many medical advances have enabled
disease treatment, increased survival
rates, and improved patient quality of
life. Early medical and therapeutic
interventions can prevent many severe
disease complications. Predicting the
severity of SCD early in the diagnosis
process can also make a remarkable
difference in the diagnosed patient’s
quality of life, making treatment and
drug prescription easier for medical
professionals.
The authors of this paper performed
a clinical review of SCD by describing
the disease and discussing available
treatment options with patients. The
team also looked at similar work that
attempted to estimate the severity of
SCD in diagnosed patients to aid
medical professionals in prescribing
drugs. Such proposed systems help
physicians, clinical pharmacists, and

any other medical professionals who
contribute to the diagnosis and drug
prescription processes for SCD patients.
This paper suggested a principle
framework system that starts with a
preprocessing step to estimate missing
data. Dimensionality reduction is
performed next to improve system
performance. The results should then be
tested with multiple widely-used ML
algorithms to produce a state-of-the-art
system that can prevent serious disease
complications. System predictions of
forthcoming SCD severity enables
accurate estimating of hydroxyurea
dosages, preventing complications.
Future research should develop an
advanced system incorporating an
intelligent support system with ML
algorithms, assisting physicians in
making decisions that save time and
enhance the quality of patient lives.
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